Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR 11.06.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-07
Name of Upcoming Event:Truist Securities BioPharma Symposium
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:Guggenheim Inaugural Healthcare Innovation Conference
Date of Upcoming Event:2024-11-14
Name of Upcoming Event:B. Riley Securities’ Next-Gen Tissue Delivery Modalities Virtual Summit
Date of Upcoming Event:2024-11-18
Name of Upcoming Event:Stifel 2024 Healthcare Conference
Full Press ReleaseSEC FilingsOur VYGR Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - Pete Stavropoulos
  • 12.03.2024 - Samantha Semenkow, Ph.D.
  • 11.20.2024 - Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

Recent Filings

  • 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.14.2025 - 144 Report of proposed sale of securities
  • 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors

LEXINGTON, Mass.,Nov. 06, 2024(GLOBE NEWSWIRE) --Voyager Therapeutics, Inc.(Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences:

  • Truist Securities BioPharma Symposium, inNew York City, including a panel discussion on Genetic Medicines at1:45 p.m. ETonNovember 7, 2024
  • Guggenheim Inaugural Healthcare Innovation Conference*, inBoston, including a fireside chat at2:00 p.m. ETonNovember 13, 2024
  • B. Riley Securities’ Next-Gen Tissue Delivery Modalities Virtual Summit, virtual, including a fireside chat at1:30 p.m. ETonNovember 14, 2024
  • Stifel 2024 Healthcare Conference*, inNew York City, including a fireside chat at9:45 a.m. ETonNovember 18, 2024

For the conferences denoted by an asterisk, webcasts will be available and may be accessed from the Investors section of Voyager’s website atir.voyagertherapeutics.com. A replay of any webcasts will be archived on the Company's website for at least 30 days.

AboutVoyager TherapeuticsVoyager Therapeutics, Inc.(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACERTM AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease;Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc. For more information, visitwww.voyagertherapeutics.com.

Voyager Therapeutics®is a registered trademark, and TRACERTM is a trademark, ofVoyager Therapeutics, Inc.

ContactsTrista Morrison, NACD.DC,tmorrison@vygr.comInvestors:Mike Hencke,mhencke@kendallir.comMedia:Brooke Shenkin,brooke@scientpr.com

Primary Logo

Source: Voyager Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com